Since 2020, TalkingChina has been offering Chinese-English translation service for CSPC, with an annual translation volume exceeding 50,000 words, primarily covering content such as press releases about new drug development and corporate updates.

The cooperation began in 2020, covering languages including Chinese and English; translated content includes registration documents; while the annual translation volume exceeds 500,000 words.

Since 2021, TalkingChina has been collaborating with Zhongmei Huadong Pharmaceutical on various language service regarding technical documentation and marketing materials translation between Chinese and English, video subtitle translation, as well as simu

Stock code: 837344. The collaboration began in 2021, covering language pairs such as Chinese-English and Chinese-German. The content includes research proposals, with an annual translation volume exceeding 200,000 words.

Since 2021, TalkingChina has been collaborating with Hengrui Pharma on high-level international medical technology exchanges, providing simultaneous and consecutive interpretation service for language pairs including Chinese-English and Chinese-Japanese.

On June 15, 2021, TalkingChina won the bid to become the translation service supplier for Sansure Biotech's 2021-2022 translation service procurement project, regarding translation between Chinese and English for product introductions among others; the an

A well-known bioactive materials company and the largest supplier of hyaluronic acid (HA) raw materials in the world. Since 2022, TalkingChina has been providing translation service for Hua Xi Biological, primarily between Chinese and English.

TalkingChina has been the framework supplier of Santen since 2015, providing Japanese and English translation and interpretation service. It has also provided simultaneous interpretation service for Santen's annual meetings in China many times, with nearl

It is a joint venture between Shanghai Pharmaceuticals and BIOCAD, Russia's largest biopharmaceutical company. Since 2020, TalkingChina has been providing translation service including English-to-Chinese for registration documents, with an annual average

One of the production enterprises with the most complete varieties of pharmaceutical-grade amino acids in China. Since 2011, TalkingChina has been providing translation and interpretation service for SHANGHAI KYOWA AMINO ACID CO., LTD. in Japanese, Englis

A pharmaceutical industry platform under the Hengdian Group, listed on the main board of the Shenzhen Stock Exchange. Since 2021, TalkingChina has been providing translation service for Apeloa, covering Chinese-Japanese and Chinese-Russian, focusing on re

The world's number one brand of human albumin. TalkingChina has been providing service to CSL Behring since 2016, primarily offering English-Chinese translation and proofreading service, with an annual volume of nearly 100,000 words.

It is the only national-level medical hi-tech zone in China. Since 2014, TalkingChina has been providing Chinese-English and Chinese-Japanese translation service for them.